Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,661,535
+$648,159 QoQ
Shares Held
2,219
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#2,238
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Occidental Asset Management, LLC holds $27,487,329 across 9 Drug Manufacturers - General names. LLY ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,777 | $7,295,844 | |
| 2 | AMGN |
Amgen Inc
|
17,469 | $6,325,874 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
34,701 | $4,384,124 | |
| 4 | ABBV |
AbbVie Inc.
|
10,577 | $2,661,596 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
2,219 | $2,661,535 | |
| 6 | JNJ |
Johnson & Johnson
|
7,491 | $1,902,489 | |
| 7 | NVS |
Novartis AG
|
10,018 | $1,570,020 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,807 | $449,839 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,661,535 | 2,219 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,013,376 | 2,189 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,271,873 | 2,114 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,549,653 | 2,031 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,532,555 | 1,966 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,613,002 | 1,953 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,138,700 | 1,475 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,290,814 | 1,457 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,346,300 | 1,487 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,219,063 | 1,567 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,000,290 | 1,716 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $984,559 | 1,833 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $859,640 | 1,833 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $543,633 | 1,583 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $579,124 | 1,583 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $498,929 | 1,543 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $500,286 | 1,543 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $458,764 | 1,602 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $431,731 | 1,563 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $361,131 | 1,563 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $349,558 | 1,523 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $284,526 | 1,523 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $243,636 | 1,443 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $213,592 | 1,443 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $236,911 | 1,443 | Shares | Sole | 2020-07-17 | |
| No filing history on record for this holder in this stock. | ||||||